Ora’s preclinical ophthalmic research team has extensive experience, ranging from identification and procurement of compounds to managing and executing animal efficacy, safety, and PK studies. Animal disease models are modified to provide a customized and accurate screening in the most efficient and cost-effective manner. We have a collaborative approach to ocular drug development through synergy with Ora’s clinical, regulatory, and CMC departments. Ora also assists with development and management of GLP toxicology programs to support regulatory filings.
Get the milestone data you need to make important decisions in the early stages of product development. Contact us to learn more about Ora’s preclinical ophthalmic research services and how we can help accelerate your product development.